(+)-CP 101,606
CAY-23884-5 5 mg
Data Sheet: 
SDS:
SDS:
CAS
134234-12-1
Formulation
A crystalline solid
Purity
≥98%
MW
327,4
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
An antagonist of NR2B subunit-containing NMDA receptors (Kd = 4.2 nM); selective for NR1/NR2B-containing NMDA receptors over NR1, NR2A, and NR2B subunits alone and NR1/NR2A receptors in HEK293 cell homogenates; suppresses mechanical hyperalgesia following carrageenan challenge in rats (30 mg/kg, s.c.); inhibits licking behavior in rats induced by capsaicin and PMA (ED50s = 7.5 and 5.7 mg/kg, respectively); reverses haloperidol-induced catalepsy in rats (ED50 = 0.4 mg/kg); temporarily improves parkinsonian symptoms in an MPTP model of Parkinson’s disease in rhesus monkeys
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
